JPWO2023237484A5 - - Google Patents
Info
- Publication number
- JPWO2023237484A5 JPWO2023237484A5 JP2024570947A JP2024570947A JPWO2023237484A5 JP WO2023237484 A5 JPWO2023237484 A5 JP WO2023237484A5 JP 2024570947 A JP2024570947 A JP 2024570947A JP 2024570947 A JP2024570947 A JP 2024570947A JP WO2023237484 A5 JPWO2023237484 A5 JP WO2023237484A5
- Authority
- JP
- Japan
- Prior art keywords
- methylene
- freeze
- tetrahydrofolic acid
- disodium salt
- citrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22177932 | 2022-06-08 | ||
| EP22177932.5 | 2022-06-08 | ||
| PCT/EP2023/064972 WO2023237484A1 (en) | 2022-06-08 | 2023-06-05 | Compositions comprising disodium 5,10-methylene-(6r)-tetrahydrofolate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025518274A JP2025518274A (ja) | 2025-06-12 |
| JPWO2023237484A5 true JPWO2023237484A5 (enExample) | 2025-12-18 |
Family
ID=81984853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024570947A Pending JP2025518274A (ja) | 2022-06-08 | 2023-06-05 | ５，１０－メチレン－（６ｒ）－テトラヒドロ葉酸二ナトリウムを含む組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250360135A1 (enExample) |
| EP (1) | EP4536187A1 (enExample) |
| JP (1) | JP2025518274A (enExample) |
| KR (1) | KR20250022145A (enExample) |
| CN (1) | CN119365186A (enExample) |
| AU (1) | AU2023282347A1 (enExample) |
| CA (1) | CA3258734A1 (enExample) |
| IL (1) | IL317395A (enExample) |
| WO (1) | WO2023237484A1 (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1215945A (en) | 1983-03-20 | 1986-12-30 | Bengt Gustavsson | Fluid transfer system |
| CH682664A5 (en) | 1991-10-15 | 1993-10-29 | Eprova Ag | Stable salts of 5,10-methylene tetrahydrofolate. |
| WO1997027764A1 (en) * | 1996-01-31 | 1997-08-07 | South Alabama Medical Science Foundation | Food and vitamin preparations containing the natural isomer of reduced folates |
| CH697021A5 (de) * | 2003-06-26 | 2008-03-31 | Merck Eprova Ag | Stabile pharmazeutische Zusammensetzungen von 5, 10-Methylentetrahydrofolat. |
| CN101321518A (zh) * | 2005-12-02 | 2008-12-10 | 阿德文特克斯药物有限公司 | 5,10-亚甲基四氢叶酸盐的稳定药物组合物 |
| EP2837631A1 (en) | 2013-08-14 | 2015-02-18 | Merck & Cie | New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid |
| US10059710B2 (en) * | 2016-02-17 | 2018-08-28 | Merck & Cie | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid |
| DK3668516T3 (da) | 2017-08-16 | 2021-12-13 | Merck Patent Gmbh | Stabile lyofilisater omfattende 5,10-methylen-(6r)-tetrahydrofolsyre og en dicarboxylsyre |
| CN107892692A (zh) * | 2017-12-28 | 2018-04-10 | 华东理工大学 | (6s)‑5‑甲基四氢叶酸锌盐的制备方法及其应用 |
-
2023
- 2023-06-05 AU AU2023282347A patent/AU2023282347A1/en active Pending
- 2023-06-05 EP EP23730517.2A patent/EP4536187A1/en active Pending
- 2023-06-05 KR KR1020257000562A patent/KR20250022145A/ko active Pending
- 2023-06-05 CA CA3258734A patent/CA3258734A1/en active Pending
- 2023-06-05 US US18/872,672 patent/US20250360135A1/en active Pending
- 2023-06-05 IL IL317395A patent/IL317395A/en unknown
- 2023-06-05 WO PCT/EP2023/064972 patent/WO2023237484A1/en not_active Ceased
- 2023-06-05 JP JP2024570947A patent/JP2025518274A/ja active Pending
- 2023-06-05 CN CN202380045351.1A patent/CN119365186A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4126680A (en) | Tetracycline antibiotic compositions | |
| JPH0356418A (ja) | 冷蔵庫温度で安定なホリニン酸塩水溶液並びにその製造方法 | |
| JP2013529201A5 (enExample) | ||
| RU2012147527A (ru) | Тетрациклиновая композиция | |
| AU2023258405B2 (en) | Folate salts for medical use | |
| US20040170701A1 (en) | Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection | |
| JP2004067682A (ja) | 抗生物質活性を有する薬学的組成物 | |
| KR100812693B1 (ko) | 항종양 효과 증강제 및 항종양제 | |
| JP2003530431A (ja) | ナフタルイミドおよび抗増殖性剤を含有する組成物 | |
| JPWO2023237484A5 (enExample) | ||
| JPH09502709A (ja) | エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物 | |
| JPH09510989A (ja) | 安定なフォリン酸塩水溶液 | |
| IL317395A (en) | Compositions containing disodium 10,5-methylene-(6R)-tetrahydrofolate | |
| JPWO1992004028A1 (ja) | 抗腫瘍効果増強剤及び抗腫瘍剤 | |
| US5075295A (en) | Novel oxytetracycline compositions | |
| JPH10338638A (ja) | 損傷皮膚修復用製剤 | |
| JPWO2020092233A5 (enExample) | ||
| JPH07215868A (ja) | 細胞内グルタチオンを刺激する方法及び組成物 | |
| JPH06505749A (ja) | １，４−置換ピペリジンの誘導体に基づく新規液体組成物 | |
| JP2000044469A (ja) | 内服液剤 | |
| US20040092592A1 (en) | Stabilized L-Arginine platelet aggregation inhibitory compositions and processes for making same | |
| JPWO1997030706A1 (ja) | 抗腫瘍剤含有組成物 | |
| US20100267824A1 (en) | Stable oxaliplatin composition for parenteral administration | |
| US20070112041A1 (en) | Nicardipine injection composition | |
| JP3236608B2 (ja) | ブレオマイシン類の安定な水溶液 |